Brainsway Ltd. Sponsored ADR (BWAY) vs Pacific Biosciences of California, Inc. (PACB)
- Brainsway Ltd. Sponsored ADR BWAY 11.41 −3.47%
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
Brainsway Ltd. Sponsored ADR and Pacific Biosciences of California, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. is the larger, with a market value of $609.2M against $475.8M — 1.3× the size. Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; Brainsway Ltd. Sponsored ADR trades at 24.8×. Brainsway Ltd. Sponsored ADR grew revenue faster over the last twelve months: 31.7% against 2.02%. Brainsway Ltd. Sponsored ADR has the higher net margin (15.6% vs −82.5%) and the higher return on invested capital (30.0% vs −22.2%). Across the 17 metrics below, Brainsway Ltd. Sponsored ADR leads on 14 and Pacific Biosciences of California, Inc. on 3.
Valuation
Profitability
| Metric | BWAY | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 75.32% | 36.38% | 56.01% |
| Operating margin | 12.46% | (83.53%) | (15.03%) |
| Net margin | 15.55% | (82.49%) | (20.40%) |
| Free cash flow margin | 9.53% | (50.53%) | (7.24%) |
| Return on equity | 12.82% | (929.31%) | (15.32%) |
| Return on assets | 8.09% | (16.66%) | (19.72%) |
| Return on invested capital | 29.98% | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack